Diagnosis and treatment of prostate cancer are on cusp of major change, conference hearsBMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.c2652 (Published 17 May 2010) Cite this as: BMJ 2010;340:c2652
- Janice Hopkins Tanne
- 1New York
“We are at a sea change” in managing prostate cancer, moving towards focal therapy for small lesions and avoiding the problems of overdiagnosis and overtreatment of prostate cancer. “The solution is going to be imaging,” said Mark Emberton, reader in interventional oncological surgery at University College Hospital, London.
He spoke to the BMJ at a meeting in New York sponsored by the UK’s Pelican Cancer Foundation that brought together experts from many disciplines. Participants emphasised the importance of imaging techniques in identifying aggressive cancers and determining when focal therapy was suitable to ablate less aggressive lesions, in a way similar to lumpectomy for breast cancer.
The Pelican Cancer Foundation works to improve the detection, management, and non-invasive treatment of prostate cancer. It believes that imaging is the key to the proper planning of care of patients with …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial